Resolving Drug Effects In Patient-Derived Cancer Cells Links Organoid Responses To Genome Alterations
J. Neugebauer, F. M. Zickgraf, J. Park, S. Wagner, X. Jiang, K. Jechow, K. Kleinheinz, U. H. Toprak, M. A. Schneider, M. Meister, S. Spaich, M. Suetterlin, M. Schlesner, A. Trumpp, M. Sprick, , C. Conrad
The paper compares drug responses in ovarian cancer organoids and monolayer cultures, finding differences in drug efficacy and genomic associations.
bioRxiv · Apr 6, 2017Cancer Biology